{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T03:08:20Z","timestamp":1779937700115,"version":"3.53.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T00:00:00Z","timestamp":1740700800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T00:00:00Z","timestamp":1740700800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"the Construction Project of Shanghai Style Traditional Chinese Medicine School Inheritance and Innovation Team","award":["2021LPTD-003"],"award-info":[{"award-number":["2021LPTD-003"]}]},{"name":"the Traditional Chinese Medicine Research Project of Shanghai Municipal Health Commission","award":["2024QN110"],"award-info":[{"award-number":["2024QN110"]}]},{"name":"Shanghai Flagship Hospital of Integrated Traditional Chinese and Western Medicine Construction Program","award":["ZY (2021-2023)-0205-01"],"award-info":[{"award-number":["ZY (2021-2023)-0205-01"]}]},{"name":"Shanghai\u2019s Three Year Action Plan for Further Accelerating the Inheritance, Innovation and Development of Traditional Chinese Medicine","award":["ZY(2021-2023)-0208"],"award-info":[{"award-number":["ZY(2021-2023)-0208"]}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["NO. 22277076"],"award-info":[{"award-number":["NO. 22277076"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["NO.82070902"],"award-info":[{"award-number":["NO.82070902"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Changzhou Science and Technology Project","award":["CJ20235004"],"award-info":[{"award-number":["CJ20235004"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Chin Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Acute gout arthritis (AGA) is a common metabolic joint disease and urgently needs a safer alternative therapy due to the significant side effects from long-term use of primary medications. <jats:italic>Folium Hibisci Mutabilis<\/jats:italic>, a traditional medicinal herb, has demonstrated promising therapeutic efficacy in the clinical management of AGA, but its pharmacological mechanisms remain to be elucidated.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>\n              <jats:italic>Folium Hibisci Mutabili<\/jats:italic> was isolated and refined <jats:italic>into<\/jats:italic> the <jats:italic>Folium Hibisci Mutabilis<\/jats:italic> Extract (FHME). Then, monosodium urate-induced AGA animal models were applied to identify the anti-inflammatory and analgesic effects of FHME in vivo through various techniques, including ultrasonography, Paw withdrawal thresholds, histological staining, etc. We used RNA-seq, qRT-PCR, ELISA, and flow cytometry to evaluate the efficacy of FHME on M1 polarization. Utilizing transmission electron microscope and oxygen consumption rate examinations in conjunction with Mito-Tracker staining, we observed the effects of FHME on mitochondrial morphology and function. Finally, we employed proteomics analysis, siRNA, qRT-PCR, western blot and other techniques to investigate the underlying mechanism of FHME's actions between the two phenotypes and the key targets.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>We observed a notable reduction in inflammation and pain, as well as the decreased infiltration of inflammatory cells and expression of IL-1\u03b2 in synovial tissue of AGA mice upon treatment with FHME. FHME suppressed TNF-\u03b1, IL-1\u03b2, iNOS, and IL-18 expression in BMDM-derived macrophages and inhibited the formation of F4\/80<jats:sup>+<\/jats:sup>CD86<jats:sup>+<\/jats:sup> cells. Mechanically, FHME protected mitochondrial morphology and stimulated the expression of key oxidative phosphorylation proteins, such as Ubiquinol Cytochrome c Reductase Core Protein I (UQCRC1), UQCRC2, CYCS, and NDUFA4. Additionally, it enhanced the activity of respiratory complex III, recovered cellular aerobic respiration under LPS and MSU induction. FHME lost its effect to downregulate M1 macrophage polarization with the presence of rotenone or si-UQCRC1. Finally, 10 compounds were identified from FHME having potential binding affinity with the UQCRC1 protein.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>The therapeutic potential of FHME for AGA is associated with the maintenance of mitochondrial function to inhibit M1 macrophage polarization, which is intimately linked to the UQCRC1. Our findings highlight the potential of <jats:italic>Folium Hibisci Mutabilis<\/jats:italic> as a safe and effective approach for AGA.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s13020-025-01081-6","type":"journal-article","created":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T10:57:14Z","timestamp":1740740234000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Folium Hibisci Mutabilis extract suppresses M1 macrophage polarization through mitochondrial function enhancement in murine acute gouty arthritis"],"prefix":"10.1186","volume":"20","author":[{"given":"Yichen","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juncheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haojun","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Honghong","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4372-8312","authenticated-orcid":false,"given":"Xiaobing","family":"Xi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,28]]},"reference":[{"issue":"21","key":"1081_CR1","doi-asserted-by":"publisher","first-page":"2399","DOI":"10.2165\/00003495-200464210-00003","volume":"64","author":"N Schlesinger","year":"2004","unstructured":"Schlesinger N. Management of acute and chronic gouty arthritis: present state-of-the-art. Drugs. 2004;64(21):2399\u2013416.","journal-title":"Drugs"},{"key":"1081_CR2","unstructured":"Collaborators GBDG. Global, regional, and national burden of gout, 1990\u20132020, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021. Lancet Rheumatol. 2024."},{"issue":"6","key":"1081_CR3","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1002\/acr.24180","volume":"72","author":"JD FitzGerald","year":"2020","unstructured":"FitzGerald JD, Dalbeth N, Mikuls T, Brignardello-Petersen R, Guyatt G, Abeles AM, et al. 2020 American college of rheumatology guideline for the management of gout. Arthritis Care Res. 2020;72(6):744\u201360.","journal-title":"Arthritis Care Res"},{"issue":"1","key":"1081_CR4","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1136\/annrheumdis-2019-215315","volume":"79","author":"P Richette","year":"2020","unstructured":"Richette P, Doherty M, Pascual E, Barskova V, Becce F, Castaneda J, et al. 2018 updated European league against rheumatism evidence-based recommendations for the diagnosis of gout. Ann Rheum Dis. 2020;79(1):31\u20138.","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"1081_CR5","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1161\/ATVBAHA.124.319851","volume":"44","author":"LF Buckley","year":"2024","unstructured":"Buckley LF, Libby P. Colchicine\u2019s role in cardiovascular disease management. Arterioscler Thromb Vasc Biol. 2024;44(5):1031\u201341.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"12","key":"1081_CR6","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.1136\/ard-2023-224154","volume":"82","author":"E Roddy","year":"2023","unstructured":"Roddy E, Bajpai R, Forrester H, Partington RJ, Mallen CD, Clarson LE, et al. Safety of colchicine and NSAID prophylaxis when initiating urate-lowering therapy for gout: propensity score-matched cohort studies in the UK clinical practice research Datalink. Ann Rheum Dis. 2023;82(12):1618\u201325.","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"1081_CR7","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1038\/nrrheum.2017.155","volume":"13","author":"AK So","year":"2017","unstructured":"So AK, Martinon F. Inflammation in gout: mechanisms and therapeutic targets. Nat Rev Rheumatol. 2017;13(11):639\u201347.","journal-title":"Nat Rev Rheumatol"},{"issue":"10287","key":"1081_CR8","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1016\/S0140-6736(21)00569-9","volume":"397","author":"N Dalbeth","year":"2021","unstructured":"Dalbeth N, Gosling AL, Gaffo A, Abhishek A. Gout. Lancet. 2021;397(10287):1843\u201355.","journal-title":"Lancet"},{"issue":"10","key":"1081_CR9","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1038\/s41374-022-00798-4","volume":"102","author":"L Zhao","year":"2022","unstructured":"Zhao L, Ye W, Zhu Y, Chen F, Wang Q, Lv X, et al. Distinct macrophage polarization in acute and chronic gout. Lab Invest. 2022;102(10):1054\u201363.","journal-title":"Lab Invest"},{"issue":"3","key":"1081_CR10","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.immuni.2015.02.002","volume":"42","author":"SE Weinberg","year":"2015","unstructured":"Weinberg SE, Sena LA, Chandel NS. Mitochondria in the regulation of innate and adaptive immunity. Immunity. 2015;42(3):406\u201317.","journal-title":"Immunity"},{"issue":"4","key":"1081_CR11","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1042\/BST20170501","volume":"46","author":"R Macdonald","year":"2018","unstructured":"Macdonald R, Barnes K, Hastings C, Mortiboys H. Mitochondrial abnormalities in Parkinson\u2019s disease and Alzheimer\u2019s disease: can mitochondria be targeted therapeutically? Biochem Soc Trans. 2018;46(4):891\u2013909.","journal-title":"Biochem Soc Trans"},{"key":"1081_CR12","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.freeradbiomed.2020.02.029","volume":"152","author":"J Yan","year":"2020","unstructured":"Yan J, Jiang J, He L, Chen L. Mitochondrial superoxide\/hydrogen peroxide: an emerging therapeutic target for metabolic diseases. Free Radic Biol Med. 2020;152:33\u201342.","journal-title":"Free Radic Biol Med"},{"key":"1081_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.115957","volume":"170","author":"D Zeng","year":"2024","unstructured":"Zeng D, Yin C, Wei H, Li Y, Yang Y, Nie H, et al. Activation of Nrf2 antioxidant signaling alleviates gout arthritis pain and inflammation. Biomed Pharmacother. 2024;170: 115957.","journal-title":"Biomed Pharmacother"},{"issue":"6","key":"1081_CR14","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.it.2017.03.001","volume":"38","author":"J Van den Bossche","year":"2017","unstructured":"Van den Bossche J, O\u2019Neill LA, Menon D. Macrophage immunometabolism: where are we (going)? Trends Immunol. 2017;38(6):395\u2013406.","journal-title":"Trends Immunol"},{"key":"1081_CR15","doi-asserted-by":"publisher","first-page":"1199751","DOI":"10.3389\/fimmu.2023.1199751","volume":"14","author":"X Li","year":"2023","unstructured":"Li X, Shen H, Zhang M, Teissier V, Huang EE, Gao Q, et al. Glycolytic reprogramming in macrophages and MSCs during inflammation. Front Immunol. 2023;14:1199751.","journal-title":"Front Immunol"},{"key":"1081_CR16","doi-asserted-by":"crossref","unstructured":"Ran L, Chen M, Ye J, Zhang S, Luo Z, Bai T, et al. UK5099 Inhibits the NLRP3 Inflammasome Independently of its Long-Established Target Mitochondrial Pyruvate Carrier. Adv Sci (Weinh). 2024:e2307224.","DOI":"10.1002\/advs.202307224"},{"issue":"1","key":"1081_CR17","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1186\/s13075-019-1974-z","volume":"21","author":"B Chen","year":"2019","unstructured":"Chen B, Li H, Ou G, Ren L, Yang X, Zeng M. Curcumin attenuates MSU crystal-induced inflammation by inhibiting the degradation of IkappaBalpha and blocking mitochondrial damage. Arthritis Res Ther. 2019;21(1):193.","journal-title":"Arthritis Res Ther"},{"key":"1081_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2021.107819","volume":"97","author":"H Yue","year":"2021","unstructured":"Yue H, Yang Z, Ou Y, Liang S, Deng W, Chen H, et al. Tanshinones inhibit NLRP3 inflammasome activation by alleviating mitochondrial damage to protect against septic and gouty inflammation. Int Immunopharmacol. 2021;97: 107819.","journal-title":"Int Immunopharmacol"},{"key":"1081_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2023.154705","volume":"112","author":"MY Kim","year":"2023","unstructured":"Kim MY, Bang E, Hwangbo H, Ji SY, Kim DH, Lee H, et al. Diallyl trisulfide inhibits monosodium urate-induced NLRP3 inflammasome activation via NOX3\/4-dependent mitochondrial oxidative stress in RAW 2647 and bone marrow-derived macrophages. Phytomedicine. 2023;112: 154705.","journal-title":"Phytomedicine"},{"key":"1081_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2022.115918","volume":"303","author":"M Xiao","year":"2023","unstructured":"Xiao M, Zhang T, Cao F, Liang W, Yang Y, Huang T, et al. Anti-influenza properties of tiliroside isolated from Hibiscus mutabilis L. J Ethnopharmacol. 2023;303: 115918.","journal-title":"J Ethnopharmacol"},{"issue":"1","key":"1081_CR21","first-page":"127","volume":"11","author":"J Wang","year":"2014","unstructured":"Wang J, Li X, Gao L, Wang X. In vitro anti-inflammatory mechanism of Folium Hibisci Mutabilis leaves ethanol extracts. Afr J Tradit Complement Altern Med. 2014;11(1):127\u201330.","journal-title":"Afr J Tradit Complement Altern Med"},{"issue":"4","key":"1081_CR22","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1097\/00000542-199510000-00017","volume":"83","author":"SR Chaplan","year":"1995","unstructured":"Chaplan SR, Bach FW, Shafer SL, Yaksh TL. Prolonged alleviation of tactile allodynia by intravenous lidocaine in neuropathic rats. Anesthesiology. 1995;83(4):775\u201385.","journal-title":"Anesthesiology"},{"issue":"11","key":"1081_CR23","doi-asserted-by":"publisher","first-page":"3352","DOI":"10.1093\/brain\/awaa279","volume":"143","author":"CH Lin","year":"2020","unstructured":"Lin CH, Tsai PI, Lin HY, Hattori N, Funayama M, Jeon B, et al. Mitochondrial UQCRC1 mutations cause autosomal dominant parkinsonism with polyneuropathy. Brain. 2020;143(11):3352\u201373.","journal-title":"Brain"},{"issue":"3","key":"1081_CR24","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/j.celrep.2016.09.008","volume":"17","author":"J Van den Bossche","year":"2016","unstructured":"Van den Bossche J, Baardman J, Otto NA, van der Velden S, Neele AE, van den Berg SM, et al. Mitochondrial dysfunction prevents repolarization of inflammatory macrophages. Cell Rep. 2016;17(3):684\u201396.","journal-title":"Cell Rep"},{"issue":"3","key":"1081_CR25","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.immuni.2015.02.017","volume":"42","author":"LA O'Neill","year":"2015","unstructured":"O\u2019Neill LA. A broken krebs cycle in macrophages. Immunity. 2015;42(3):393\u20134.","journal-title":"Immunity"},{"issue":"10","key":"1081_CR26","doi-asserted-by":"publisher","first-page":"8516","DOI":"10.1074\/jbc.M210432200","volume":"278","author":"N Li","year":"2003","unstructured":"Li N, Ragheb K, Lawler G, Sturgis J, Rajwa B, Melendez JA, et al. Mitochondrial complex I inhibitor rotenone induces apoptosis through enhancing mitochondrial reactive oxygen species production. J Biol Chem. 2003;278(10):8516\u201325.","journal-title":"J Biol Chem"},{"key":"1081_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2022.154548","volume":"109","author":"CL He","year":"2023","unstructured":"He CL, Tang Y, Chen X, Long T, He YN, Wei J, et al. Folium Hibisci Mutabilis extract, a potent autophagy enhancer, exhibits neuroprotective properties in multiple models of neurodegenerative diseases. Phytomedicine. 2023;109: 154548.","journal-title":"Phytomedicine"},{"key":"1081_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2024.118182","volume":"330","author":"S Wang","year":"2024","unstructured":"Wang S, Liu W, Wei B, Wang A, Wang Y, Wang W, et al. Traditional herbal medicine: therapeutic potential in acute gouty arthritis. J Ethnopharmacol. 2024;330: 118182.","journal-title":"J Ethnopharmacol"},{"issue":"3","key":"1081_CR29","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1053\/j.ajkd.2017.01.055","volume":"70","author":"AB Vargas-Santos","year":"2017","unstructured":"Vargas-Santos AB, Neogi T. Management of gout and hyperuricemia in CKD. Am J Kidney Dis. 2017;70(3):422\u201339.","journal-title":"Am J Kidney Dis"},{"key":"1081_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2023.110466","volume":"121","author":"W Liu","year":"2023","unstructured":"Liu W, Peng J, Wu Y, Ye Z, Zong Z, Wu R, et al. Immune and inflammatory mechanisms and therapeutic targets of gout: an update. Int Immunopharmacol. 2023;121: 110466.","journal-title":"Int Immunopharmacol"},{"key":"1081_CR31","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.955806","volume":"13","author":"L Liu","year":"2022","unstructured":"Liu L, Zhu L, Liu M, Zhao L, Yu Y, Xue Y, et al. Recent insights into the role of macrophages in acute gout. Front Immunol. 2022;13: 955806.","journal-title":"Front Immunol"},{"issue":"1","key":"1081_CR32","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1186\/s12906-021-03364-5","volume":"21","author":"HF Fan","year":"2021","unstructured":"Fan HF, Fang XY, Wu HL, Xu YQ, Gong LC, Yu DR, et al. Effects of Stephania hainanensis alkaloids on MSU-induced acute gouty arthritis in mice. BMC Complement Med Ther. 2021;21(1):202.","journal-title":"BMC Complement Med Ther"},{"issue":"7","key":"1081_CR33","doi-asserted-by":"publisher","first-page":"2897","DOI":"10.7150\/thno.40495","volume":"10","author":"Y Li","year":"2020","unstructured":"Li Y, He Y, Miao K, Zheng Y, Deng C, Liu TM. Imaging of macrophage mitochondria dynamics in vivo reveals cellular activation phenotype for diagnosis. Theranostics. 2020;10(7):2897\u2013917.","journal-title":"Theranostics"},{"issue":"10\u201312","key":"1081_CR34","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1089\/ars.2023.0268","volume":"39","author":"I Kawano","year":"2023","unstructured":"Kawano I, Bazila B, Jezek P, Dlaskova A. Mitochondrial dynamics and cristae shape changes during metabolic reprogramming. Antioxid Redox Signal. 2023;39(10\u201312):684\u2013707.","journal-title":"Antioxid Redox Signal"},{"key":"1081_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2020.101674","volume":"37","author":"D Nolfi-Donegan","year":"2020","unstructured":"Nolfi-Donegan D, Braganza A, Shiva S. Mitochondrial electron transport chain: oxidative phosphorylation, oxidant production, and methods of measurement. Redox Biol. 2020;37: 101674.","journal-title":"Redox Biol"},{"issue":"3","key":"1081_CR36","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.cmet.2012.07.015","volume":"16","author":"E Balsa","year":"2012","unstructured":"Balsa E, Marco R, Perales-Clemente E, Szklarczyk R, Calvo E, Landazuri MO, et al. NDUFA4 is a subunit of complex IV of the mammalian electron transport chain. Cell Metab. 2012;16(3):378\u201386.","journal-title":"Cell Metab"},{"issue":"7","key":"1081_CR37","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1007\/s00018-019-03007-6","volume":"76","author":"W Shan","year":"2019","unstructured":"Shan W, Li J, Xu W, Li H, Zuo Z. Critical role of UQCRC1 in embryo survival, brain ischemic tolerance and normal cognition in mice. Cell Mol Life Sci. 2019;76(7):1381\u201396.","journal-title":"Cell Mol Life Sci"},{"issue":"8","key":"1081_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2021.166147","volume":"1867","author":"D Burska","year":"2021","unstructured":"Burska D, Stiburek L, Krizova J, Vanisova M, Martinek V, Sladkova J, et al. Homozygous missense mutation in UQCRC2 associated with severe encephalomyopathy, mitochondrial complex III assembly defect and activation of mitochondrial protein quality control. Biochim Biophys Acta Mol Basis Dis. 2021;1867(8): 166147.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"12","key":"1081_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.109729","volume":"36","author":"YC Hung","year":"2021","unstructured":"Hung YC, Huang KL, Chen PL, Li JL, Lu SH, Chang JC, et al. UQCRC1 engages cytochrome c for neuronal apoptotic cell death. Cell Rep. 2021;36(12): 109729.","journal-title":"Cell Rep"},{"key":"1081_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpba.2022.114869","volume":"218","author":"CY Wu","year":"2022","unstructured":"Wu CY, Guo YY, Zhou J, Long F, Zhang W, Shen H, et al. Holistic quality evaluation of Hibisci Mutabilis Folium by integrating UPLC-QTOF-MS\/MS chemical profiling and UPLC-TQ-MS\/MS quantification approaches. J Pharm Biomed Anal. 2022;218: 114869.","journal-title":"J Pharm Biomed Anal"}],"container-title":["Chinese Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13020-025-01081-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13020-025-01081-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13020-025-01081-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T10:57:34Z","timestamp":1740740254000},"score":1,"resource":{"primary":{"URL":"https:\/\/cmjournal.biomedcentral.com\/articles\/10.1186\/s13020-025-01081-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,28]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1081"],"URL":"https:\/\/doi.org\/10.1186\/s13020-025-01081-6","relation":{},"ISSN":["1749-8546"],"issn-type":[{"value":"1749-8546","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,28]]},"assertion":[{"value":"10 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiments were conducted following the approval of Vital River Laboratory Animal Technologies Co., LTD's Institutional Animal Care and Use Committee (IACUC), with the ethical Approval number PA23021701.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors agree to publish this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors declare that they have no actual or potential competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"28"}}